It was reported that the patient was deceased due to episodes of ventricular fibrillation (vf) in which the device was unable to terminate the arrhythmia.Technical support was contacted and noted that there were four episodes of vf, three of which the device delivered anti-tachycardia pacing (atp) and shock therapy, but the device did not deliver a shock in the fourth episode.It was suggested by technical support that undersensing may have led to the vf not being detected because the patient¿s signal amplitudes were very low.The device behaved according to its programmed settings in each of the episodes and no malfunction was suspected.The device was explanted following the death.
|
Upon receipt, the device was interrogated with a programmer and the device image was retrieved.The device¿s sensing, pacing, lead impedance, high voltage (hv) charging, hv delivery, and hv shock impedance were tested, and the device¿s function was normal.The device had not reached elective replacement indicator (eri) or end of service (eos).A visual inspection was performed, and bodily fluids were observed in the header, no other anomalies were observed.The device session records were reviewed by technical services.The device behavior was found to be normal and the device behaved according to its programmed settings.The reported event of intermittent undersensing and inhibition of high voltage output was not confirmed.The loss of therapy was due to low signal amplitudes.
|